MCID: RTC009
MIFTS: 48

Reticulum Cell Sarcoma

Categories: Blood diseases, Cancer diseases, Rare diseases

Aliases & Classifications for Reticulum Cell Sarcoma

MalaCards integrated aliases for Reticulum Cell Sarcoma:

Name: Reticulum Cell Sarcoma 57 59
Dendritic Cell Sarcoma, Interdigitating 73
Interdigitating Dendritic Cell Sarcoma 59
Interdigitating Cell Sarcoma 59
Reticulosarcoma 73

Characteristics:

Orphanet epidemiological data:

59

OMIM:

57
Inheritance:
autosomal recessive in several families


Classifications:



External Ids:

OMIM 57 267730
Orphanet 59 ORPHA86900
UMLS via Orphanet 74 C1260326 C0024302
MESH via Orphanet 45 D054739
ICD10 via Orphanet 34 C96.4
MedGen 42 C0024302

Summaries for Reticulum Cell Sarcoma

MalaCards based summary : Reticulum Cell Sarcoma, also known as dendritic cell sarcoma, interdigitating, is related to interdigitating dendritic cell sarcoma and spindle cell sarcoma, and has symptoms including fever, fatigue and night sweats. An important gene associated with Reticulum Cell Sarcoma is VIM (Vimentin), and among its related pathways/superpathways are Innate Immune System and Cytoskeletal Signaling. The drugs Cyclophosphamide and Gemcitabine have been mentioned in the context of this disorder. Affiliated tissues include bone, brain and testis, and related phenotypes are sarcoma and cellular

Description from OMIM: 267730

Related Diseases for Reticulum Cell Sarcoma

Diseases related to Reticulum Cell Sarcoma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 246)
# Related Disease Score Top Affiliating Genes
1 interdigitating dendritic cell sarcoma 34.2 CR1 CR2 PTPRC
2 spindle cell sarcoma 30.5 ACTC1 DES MUC1 VIM
3 leiomyosarcoma 30.1 ACTC1 DES S100A1 VIM
4 histiocytic sarcoma 30.1 CR1 CR2
5 retroperitoneal fibrosis 30.0 PTPRC VIM
6 follicular dendritic cell sarcoma 29.9 CR1 CR2 FCER2
7 leukemia, chronic lymphocytic 29.7 CR2 FCER2 PTPRC TNFRSF8
8 reticulosarcoma 29.6 MUC1 PTPRC TNFRSF8
9 sarcoma 11.2
10 lymphosarcoma 10.6
11 lymphoma 10.6
12 leukemia 10.4
13 melanoma 10.4
14 brain sarcoma 10.3
15 lymphangiectasis 10.3 ACTC1 VIM
16 glomangiomyoma 10.2 ACTC1 VIM
17 lymphangioma 10.2 ACTC1 VIM
18 parapharyngeal meningioma 10.2 CR1 CR2
19 intravascular papillary endothelial hyperplasia 10.2 ACTC1 VIM
20 polyclonal hypergammaglobulinemia 10.2 CD2 CD4
21 epulis 10.2 DES VIM
22 lobomycosis 10.2 CD2 CR2
23 infantile digital fibromatosis 10.2 DES VIM
24 lymphangiomatosis 10.2 DES VIM
25 langerhans cell sarcoma 10.2 CR1 CR2
26 malignant ectomesenchymoma 10.2 DES S100A1
27 spiradenoma 10.2 ACTC1 VIM
28 malignant peritoneal mesothelioma 10.2 MUC1 VIM
29 angiocentric glioma 10.2 ACTC1 VIM
30 secretory meningioma 10.2 MUC1 VIM
31 ovarian fibrothecoma 10.2 ACTC1 DES
32 fibrous meningioma 10.2 MUC1 VIM
33 fibroblastic rheumatism 10.2 ACTC1 DES
34 chordoid meningioma 10.2 MUC1 VIM
35 nodular hidradenoma 10.2 MUC1 VIM
36 hidradenoma 10.2 MUC1 VIM
37 clear cell ependymoma 10.2 MUC1 VIM
38 botryoid rhabdomyosarcoma 10.2 ACTC1 DES
39 eccrine porocarcinoma 10.2 MUC1 VIM
40 sternum cancer 10.2 TNFRSF8 VIM
41 endometrial mucinous adenocarcinoma 10.2 MUC1 VIM
42 bile duct adenoma 10.2 MUC1 VIM
43 glomangioma 10.2 ACTC1 DES
44 cystic nephroma 10.2 DES VIM
45 clear cell meningioma 10.2 MUC1 VIM
46 myxopapillary ependymoma 10.2 MUC1 VIM
47 multicentric reticulohistiocytosis 10.2 PTPRC VIM
48 monophasic synovial sarcoma 10.2 MUC1 VIM
49 juvenile xanthogranuloma 10.2 DES VIM
50 extracutaneous mastocytoma 10.2 CD2 PTPRC

Graphical network of the top 20 diseases related to Reticulum Cell Sarcoma:



Diseases related to Reticulum Cell Sarcoma

Symptoms & Phenotypes for Reticulum Cell Sarcoma

Symptoms via clinical synopsis from OMIM:

57
Oncology:
reticulum cell sarcoma


Clinical features from OMIM:

267730

Human phenotypes related to Reticulum Cell Sarcoma:

32
# Description HPO Frequency HPO Source Accession
1 sarcoma 32 HP:0100242

UMLS symptoms related to Reticulum Cell Sarcoma:


fever, fatigue, night sweats

MGI Mouse Phenotypes related to Reticulum Cell Sarcoma:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cellular MP:0005384 9.61 ACTC1 CD4 DES FCER2 LYVE1 PTPRC
2 hematopoietic system MP:0005397 9.23 CD4 CR2 FCER2 LYVE1 PTPRC S100A9

Drugs & Therapeutics for Reticulum Cell Sarcoma

Drugs for Reticulum Cell Sarcoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 501)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 6055-19-2, 50-18-0 2907
2
Gemcitabine Approved Phase 4,Phase 3,Phase 2,Phase 1 95058-81-4 60750
3
Vincristine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 57-22-7, 2068-78-2 5978
4
Etoposide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 33419-42-0 36462
5
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 50-02-2 5743
6
Dexamethasone acetate Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1177-87-3
7
Cisplatin Approved Phase 4,Phase 3,Phase 2,Phase 1 15663-27-1 2767 441203 84093
8
Ifosfamide Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 3778-73-2 3690
9
Epirubicin Approved Phase 4,Phase 2 56420-45-2 41867
10
Prednisone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 53-03-2 5865
11
Thiotepa Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 52-24-4 5453
12
Lenograstim Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 135968-09-1
13
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 50-24-8 5755
14
leucovorin Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 58-05-9 6006 143
15
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 83-43-2 6741
16
Vindesine Approved, Investigational Phase 4,Not Applicable 59917-39-4, 53643-48-4 40839
17
Methotrexate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-05-2, 1959-05-2 126941
18
Prednisolone phosphate Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 302-25-0
19
Cytarabine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 147-94-4 6253
20
Methylprednisolone hemisuccinate Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2921-57-5
21
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 23214-92-8 31703
22
rituximab Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 174722-31-7 10201696
23
Mechlorethamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-75-2 4033
24
Crizotinib Approved Phase 4,Phase 1,Phase 2 877399-52-5 11626560 10366136 10366137 10366138 10366139 10366140 10366141
25
Folic Acid Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 59-30-3 6037
26
Doxil Approved June 1999 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 31703
27
Prednisolone hemisuccinate Experimental Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 2920-86-7
28
Pirarubicin Investigational Phase 4 72496-41-4
29
Isophosphamide mustard Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 0
30 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
31 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
32 Antineoplastic Agents, Alkylating Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
33 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
34 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
35 Immunologic Factors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
36 Antineoplastic Agents, Hormonal Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
37 Antimitotic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable
38 Alkylating Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
39 Hormones Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
40 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
41 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
42 Immunosuppressive Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
43 BB 1101 Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
44 Etoposide phosphate Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
46 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
47 glucocorticoids Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
48 Antilymphocyte Serum Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
49 Antimetabolites Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1
50 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1

Interventional clinical trials:

(show top 50) (show all 885)
# Name Status NCT ID Phase Drugs
1 CEOP/IVE/GDP Compared With CEOP as the First-line Therapy for Newly Diagnosed Adult Patients With PTCL Unknown status NCT02533700 Phase 4 CEOP/IVE/GDP chemotherapy regimen;CEOP chemotherapy regimen for 6 cycles
2 Bone Marrow Transplantation in Treating Patients With Hematologic Cancer Completed NCT00003398 Phase 4 cyclophosphamide;thiotepa
3 Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-grade Lymphoma in Adults Completed NCT00199082 Phase 4 Adriamycin;Cyclophosphamide;Cytarabine;Dexamethasone/Prednisolone;VP16;Ifosfamide;Methotrexate;G-CSF;Rituximab;Vincristine/Vindesine
4 Study of Brentuximab Vedotin in Patients With Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma Recruiting NCT01909934 Phase 4 brentuximab vedotin
5 Crizotinib Combined With Etoposide Capsule Followed by Auto-HSCT for Relapsed and Refractory ALK+ ALCL Recruiting NCT03707847 Phase 4 Crizotinib;Etoposide Capsule
6 CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma Active, not recruiting NCT01746992 Phase 4 Cyclophosphamide 750mg/m2;Vincristine 1.4mg/m2;Doxorubicin 50mg/m2;prednisone 60mg/m2;ifosfamide 2000mg/m2;pirarubicin 50mg/m2;pirarubicin 25mg/m2;Etoposide phosphate 100mg/m2;methotrexate 1500mg/m2
7 A Study of Treatment ALK(+) Systemic Anaplastic Large Cell Lymphoma With Crizotinib Withdrawn NCT02487316 Phase 4 crizotinib
8 Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma Unknown status NCT00006455 Phase 3 cyclophosphamide;cytarabine;dexamethasone;doxorubicin hydrochloride;etoposide;ifosfamide;leucovorin calcium;methotrexate;therapeutic hydrocortisone;vinblastine sulfate
9 Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia Unknown status NCT00445497 Phase 3 amoxicillin-clavulanate potassium;ciprofloxacin
10 Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain Unknown status NCT01316744 Phase 3 ketamine hydrochloride
11 Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00052936 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
12 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
13 Chemotherapy and Radiation Therapy Plus Bone Marrow Transplantation in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00003815 Phase 3 carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisolone;vincristine sulfate
14 Monoclonal Antibodies in Detecting Residual Disease in Patients Who Have Been Treated for Non-Hodgkin's Lymphoma Unknown status NCT00003338 Phase 2, Phase 3
15 Radiolabeled Monoclonal Antibody in the Detection and Staging of Patients With Non-Hodgkin's Lymphoma Unknown status NCT00003337 Phase 3
16 Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma Unknown status NCT00028717 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
17 Combination Chemotherapy With or Without Idarubicin and Peripheral Stem Cell Transplantation in Treating Patients With Leukemia or Myelodysplastic Syndrome Unknown status NCT00002989 Phase 3 busulfan;cyclophosphamide;idarubicin;melphalan
18 Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma Unknown status NCT00003423 Phase 3 asparaginase;cyclophosphamide;cytarabine;daunorubicin hydrochloride;dexamethasone;etoposide;mercaptopurine;methotrexate;prednisolone;thioguanine;vincristine sulfate
19 Combination Chemotherapy Followed By Radiation Therapy in Treating Patients With Aggressive Non-Hodgkin's Lymphoma Unknown status NCT00053768 Phase 3 EPOCH regimen;cyclophosphamide;doxorubicin hydrochloride;etoposide;prednisone;vincristine sulfate
20 High Dose Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Intermediate- or High-Grade Non-Hodgkin's Lymphoma Unknown status NCT00003578 Phase 3 CHOP regimen;carmustine;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;melphalan;prednisone;vincristine sulfate
21 Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma Unknown status NCT00003924 Phase 3
22 Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma Completed NCT00059839 Phase 3 doxorubicin hydrochloride;mercaptopurine;methotrexate;prednisone;vinblastine sulfate;vincristine sulfate
23 Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma Completed NCT00052923 Phase 3 carmustine;cyclophosphamide;etoposide
24 Combination Chemotherapy in Treating Pediatric Patients With Advanced-Stage Large Cell Lymphoma Completed NCT00002618 Phase 3 cytarabine;doxorubicin hydrochloride;leucovorin calcium;mercaptopurine;methotrexate;prednisone;vincristine sulfate
25 Two Different Methods of Collecting Stem Cells For an Autologous Stem Cell Transplant in Treating Patients With Diffuse Large Cell Lymphoma Completed NCT00566228 Phase 3
26 A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Participants With CD30-Positive Cutaneous T-Cell Lymphoma (ALCANZA Study) Completed NCT01578499 Phase 3 Brentuximab Vedotin;Methotrexate;Bexarotene
27 R-CHOP-14 Versus R-CHOP-21 and Darbepoetin Alpha in Patients Aged 60-80 Years With Diffuse Large B-cell Lymphoma Completed NCT00144755 Phase 3 Darbepoetin alfa
28 ACVBP Plus Rituximab Versus CHOP Plus Rituximab in Patients With Diffuse Large B-cell Lymphoma and Age-adjusted IPI of 1 Completed NCT00140595 Phase 3 rituximab;doxorubicin;cyclophosphamide
29 Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00012051 Phase 3 carmustine;cisplatin;cytarabine;dexamethasone;etoposide;ifosfamide;melphalan;methotrexate
30 Combination Chemotherapy With or Without Rituximab in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00064116 Phase 3 CHOP regimen
31 Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications Completed NCT00799461 Phase 3
32 Radiation Therapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma Who Have Undergone Stem Cell Transplantation Completed NCT00031668 Phase 3
33 Combination Chemotherapy With or Without Monoclonal Antibody Therapy in Treating Patients With Previously Untreated HIV-Associated Non-Hodgkin's Lymphoma Completed NCT00003595 Phase 3 CHOP regimen;cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
34 Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma Completed NCT00002649 Phase 3 cyclophosphamide;etoposide
35 Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial Completed NCT00750009 Phase 3
36 American Ginseng in Treating Patients With Fatigue Caused by Cancer Completed NCT00719563 Phase 3 American ginseng
37 Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain Completed NCT00666211 Phase 3
38 Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer Completed NCT00661999 Phase 3 sodium ferric gluconate complex in sucrose
39 Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
40 Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment Completed NCT00006348 Phase 3 ondansetron
41 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
42 Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Aggressive Non-Hodgkin's Lymphoma Completed NCT00003215 Phase 3 CHOP regimen;cyclophosphamide;cytarabine;doxorubicin hydrochloride;etoposide;leucovorin calcium;melphalan;methotrexate;methylprednisolone;mitoxantrone hydrochloride;prednisone;therapeutic hydrocortisone;vincristine sulfate
43 Comparison of Nutritional Supplements in Preventing Weight Loss in Patients With Cancer Completed NCT00053053 Phase 3
44 St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer Completed NCT00005805 Phase 3
45 Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter Completed NCT00006083 Phase 3 Fragmin
46 Rituximab and Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma Completed NCT00278421 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
47 Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Completed NCT00278408 Phase 3 cyclophosphamide;doxorubicin hydrochloride;prednisone;vincristine sulfate
48 Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer Completed NCT00070382 Phase 3 darbepoetin alfa;epoetin alfa
49 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
50 Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma Completed NCT00005590 Phase 3 levofloxacin

Search NIH Clinical Center for Reticulum Cell Sarcoma

Genetic Tests for Reticulum Cell Sarcoma

Anatomical Context for Reticulum Cell Sarcoma

MalaCards organs/tissues related to Reticulum Cell Sarcoma:

41
Bone, Brain, Testis, Cervix, T Cells, Small Intestine, Lymph Node

Publications for Reticulum Cell Sarcoma

Articles related to Reticulum Cell Sarcoma:

(show top 50) (show all 561)
# Title Authors Year
1
A Rare Case of Cytokeratin-Positive Interstitial Reticulum Cell Sarcoma and Review of the Entity. ( 27217677 )
2015
2
Cytokeratin-positive interstitial reticulum cell sarcoma: extranodal presentations mimicking carcinoma. ( 24056661 )
2013
3
Cytokeratin-positive interstitial reticulum cell sarcoma: a case report with cytological, immunohistochemical, and ultrastructural findings. ( 19207304 )
2009
4
Metastatic fibroblastic reticulum cell sarcoma of the liver: pathological and PET-CT evaluation. ( 19291544 )
2009
5
Sarcoma of follicular dendritic cells with features of sinus lining cells--a new subtype of reticulum cell sarcoma? ( 18386053 )
2008
6
Multifocal pigment epithelial detachments by reticulum cell sarcoma: a characteristic funduscopic picture. 1984. ( 15035397 )
2003
7
Reticulum cell sarcoma of lymph node with mixed dendritic and fibroblastic features. ( 11598178 )
2001
8
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. ( 9766802 )
1998
9
Interdigitating reticulum-cell sarcoma of the intestine: a case report and review of the literature. ( 9285196 )
1997
10
Direct correlation between expression of endogenous inducible nitric oxide synthase and regression of M5076 reticulum cell sarcoma hepatic metastases in mice treated with liposomes containing lipopeptide CGP 31362. ( 7541713 )
1995
11
A lymph node interdigitating reticulum cell sarcoma. ( 8311662 )
1994
12
True histiocytic lymphoma of small intestine. Analysis of two S-100 protein-positive cases with features of interdigitating reticulum cell sarcoma. ( 8379537 )
1993
13
Synergistic antitumor effects of carboplatin and interferons on hepatic metastases of colon carcinoma 26 and M5076 reticulum cell sarcoma. ( 8370655 )
1993
14
Antitumor activity and tissue distribution of bis(bilato)-1,2-cyclohexanediammineplatinum(II) complexes in BDF1 mice with murine reticulum cell sarcoma (M5076). ( 8330302 )
1993
15
Retroperitoneal reticulum cell sarcoma: a cause of paraneoplastic pemphigus. ( 8434295 )
1993
16
Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). ( 1495797 )
1992
17
Interdigitating reticulum cell sarcoma with unusual features. ( 1799028 )
1991
18
Retinal artery obstruction and atheromas associated with non-Hodgkin's large cell lymphoma (reticulum cell sarcoma). ( 1867559 )
1991
19
Re: S. Pulciani et al., Detection of a transforming gene in spontaneous reticulum cell sarcoma of SJL/J mice: genetically linked and host-dependent neoplasia. ( 1985793 )
1991
20
Interdigitating Reticulum Cell Sarcoma Positive immunohistochemistry for HLA-DR and two other activation antigens, CD30(Ki-1) and CD25(IL2R). ( 27467676 )
1991
21
Reticulum cell sarcoma: two complete 'spontaneous' regressions, in response to high-dose ascorbic acid therapy. A report on subsequent progress. ( 1749589 )
1991
22
Spindle cell neoplasms of lymph nodes of probable reticulum cell lineage. True reticulum cell sarcoma? ( 2158241 )
1990
23
Femoral head sclerosis as a presentation of reticulum cell sarcoma of the femoral neck. ( 2203903 )
1990
24
The in vivo depletion of V beta 17a+ T cells results in the inhibition of reticulum cell sarcoma growth in SJL/J mice. Evidence for the use of anticlonotypic antibody therapy in the control of malignancy. ( 2663994 )
1989
25
Evaluation of combinations of CuDIPS, Tween 80 and cyclophosphamide as therapy for reticulum cell sarcoma in SJL/J mice. ( 2665634 )
1989
26
A case of ocular reticulum cell sarcoma responded to radiation therapy. ( 2685701 )
1989
27
Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. ( 3050698 )
1988
28
The SJL/J T cell response to both spontaneous and transplantable syngeneic reticulum cell sarcoma is mediated predominantly by the V beta 17a+ T cell clonotype. ( 2460577 )
1988
29
Treatment of reticulum cell sarcoma in SJL/J mice with Tween 80. ( 3064715 )
1988
30
Ocular reticulum cell sarcoma. A case report. ( 3277294 )
1988
31
Regulation of Ia+ reticulum cell sarcoma (RCS) growth in syngeneic SJL/J mice. I. Inhibition of tumor growth by passive administration of L3T4 monoclonal antibody before or after tumor inoculation. ( 2953807 )
1987
32
Disseminated aspergillosis in a patient with ocular reticulum cell sarcoma. ( 3307899 )
1987
33
Intraocular reticulum cell sarcoma: diagnosis by choroidal biopsy. ( 3314978 )
1987
34
Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. ( 3323986 )
1987
35
Detection of a transforming gene in spontaneous reticulum cell sarcoma of SJL/J mice: genetically linked and host-dependent neoplasia. ( 3539324 )
1987
36
Mapping of SJL/J reticulum cell sarcoma tumor-associated Ia antigens by T cell hybridomas: characterization of tumor-specific and shared epitopes detected on IE+ allogeneic cells. ( 2424977 )
1986
37
Lymph node interdigitating reticulum cell sarcoma. ( 2939710 )
1986
38
Lymphoid cell populations in splenectomized and nonsplenectomized SJL/J mice bearing Hodgkin's disease-like reticulum cell sarcoma. ( 2947988 )
1986
39
Inhibition of IA positive reticulum cell sarcoma tumor cell growth in syngeneic SJL/J mice by passive administration of monoclonal anti-IA antibody. ( 3518916 )
1986
40
Regulation of reticulum cell sarcoma tumor growth in SJL/J mice by a serum inhibitor affecting T-cell proliferation. ( 3884142 )
1985
41
Post-transplantation reticulum-cell sarcoma reclassified as B-cell lymphoma. ( 3887164 )
1985
42
Non-H-2-linked control of in vivo growth of SJL/J-derived reticulum cell sarcoma in recombinant inbred strains between BALB/cKe and SJL/J mice. ( 3900512 )
1985
43
Ocular reticulum cell sarcoma. Clinicopathologic correlation of a case with multifocal lesions. ( 3901167 )
1985
44
Intimate host-tumor interaction in the spontaneous reticulum cell sarcoma of SJL/J mice: is it an exceptional case? ( 3915388 )
1985
45
Clinical aspects of ocular reticulum cell sarcoma. ( 3916292 )
1985
46
Primary reticulum cell sarcoma of the brain presenting as steroid-responsive optic neuropathy. ( 6233304 )
1984
47
Burkitt-type lymphoma and reticulum-cell sarcoma. An unusual mixed form of two intracranial primary malignant lymphomas. ( 6359511 )
1984
48
Inhibited growth of a reticulum cell sarcoma (M5076) induced in vitro and in vivo by macrophage-activating agents. ( 6372993 )
1984
49
Combined malignant lymphoma of the eye and CNS (reticulum-cell sarcoma). Report of three cases. ( 6376729 )
1984
50
Reticulum cell sarcoma with unusual presenting features: fever and low cerebrospinal fluid glucose levels. ( 6386133 )
1984

Variations for Reticulum Cell Sarcoma

Expression for Reticulum Cell Sarcoma

Search GEO for disease gene expression data for Reticulum Cell Sarcoma.

Pathways for Reticulum Cell Sarcoma

GO Terms for Reticulum Cell Sarcoma

Cellular components related to Reticulum Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 plasma membrane GO:0005886 9.73 CD2 CD4 CR1 CR2 DES FCER2
2 integral component of plasma membrane GO:0005887 9.7 CD2 CD4 CR1 FCER2 LYVE1 MUC1
3 external side of plasma membrane GO:0009897 9.56 CD2 CD4 FCER2 PTPRC
4 I band GO:0031674 9.37 ACTC1 S100A1
5 extracellular exosome GO:0070062 9.36 ACTC1 CR1 CR2 DES FCER2 LYVE1
6 membrane GO:0016020 10.1 ACTC1 CD2 CD4 CR1 CR2 DES

Biological processes related to Reticulum Cell Sarcoma according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 viral process GO:0016032 9.76 CD4 CR1 CR2 VIM
2 cytokine-mediated signaling pathway GO:0019221 9.56 CD4 FCER2 MUC1 VIM
3 cytokine production GO:0001816 9.49 CD4 S100A9
4 heterotypic cell-cell adhesion GO:0034113 9.48 CD2 PTPRC
5 positive regulation of nitric-oxide synthase activity GO:0051000 9.43 FCER2 S100A1
6 intermediate filament organization GO:0045109 9.4 DES VIM
7 complement receptor mediated signaling pathway GO:0002430 9.37 CR1 CR2
8 positive regulation of interleukin-2 biosynthetic process GO:0045086 9.32 CD4 PTPRC
9 positive regulation of humoral immune response mediated by circulating immunoglobulin GO:0002925 9.16 FCER2 PTPRC
10 T cell activation GO:0042110 9.13 CD2 CD4 PTPRC
11 muscle filament sliding GO:0030049 8.8 ACTC1 DES VIM

Molecular functions related to Reticulum Cell Sarcoma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 virus receptor activity GO:0001618 9.13 CD4 CR1 CR2
2 transmembrane signaling receptor activity GO:0004888 8.92 CD4 CR2 LYVE1 TNFRSF8

Sources for Reticulum Cell Sarcoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....